Skip to content
Log in
Sponsored AI Networking Cookbook: Practical recipes for AI-assisted network automation and development AI Networking Cookbook: Practical recipes for AI-assisted network automation and development

Author

C. Jangme

h-index 2 View on Semantic Scholar

We have 4 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Nanostructured Cubosomal Gels for Targeted Drug Delivery in Rheumatoid Arthritis: Advances in Nanomedicine and Therapeutic Nanotechnology.

Introduction/ Objective: Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovial joints, leading to joint destruction and systemic complications. Existing therapies, such as Disease-Modifying Antirheumatic Drugs (DMARDs) and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs),...

Ashok Thulluru, C. Jangme, Vrushabh Patil · 0 citations
Review Sep 2026

Heat Shock Protein 90 as a Master Regulator of Multidrug Resistance: Small-molecule Inhibitors, Prodrugs, Hybrid Molecules, Antibody-drug Conjugates, and Nanotechnology-based Delivery Systems.

INTRODUCTION/OBJECTIVE Multidrug Resistance (MDR) remains a major obstacle to effective cancer chemotherapy, driven by multiple interconnected mechanisms, including overexpression of ATP-binding Cassette (ABC) transporters, enhanced DNA repair, apoptosis evasion, and protumorigenic microenvironmental factors. Heat Shoc...

Sundeep Kadasi, A. Kholkumbe, C. Jangme et al. · 0 citations
Review Open access Sep 2026

Proteolysis targeting chimeras for drug discovery from mechanistic basis to clinical translation

Advances establish PROTAC technology as a transformative platform in modern drug discovery while emphasizing the scientific and translational challenges that must be addressed to enable broader clinical application.

S. Badadhe, Vikas B. Gawali, Mahesh D. Bhalsing et al. · 0 citations
Aug 2026

Tetrazole–imidazole hybrid derivatives as potential EGFR tyrosine kinase inhibitors: design, synthesis and in silico evaluation with preliminary antiproliferative assessment

Combined computational and preliminary cell-based findings support compound 4i as a promising lead for further investigation of EGFR-targeted anticancer activity and biochemical EGFR kinase inhibition and target-engagement studies are required to determine the mechanism of action.

S. Badadhe, Vikas B. Gawali, C. Jangme et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.